Kolexia
Nahon Sophie
Oncologie médicale
Chi Site D'aix En Provence
Aix-en-Provence, France
84 Activités
4 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du côlon Métastase tumorale Seconde tumeur primitive Anémie Tumeurs hématologiques Fragilité Tumeurs du pancréas Neutropénie fébrile induite par la chimiothérapie Neutropénie

Industries

A+A
94 collaboration(s)
Dernière en 2023
B3TSI
26 collaboration(s)
Dernière en 2023
Novartis
15 collaboration(s)
Dernière en 2023
MSD
14 collaboration(s)
Dernière en 2023

Dernières activités

ORHEO: Role of biOsimilaRs in Therapeutic Management of Anemia Following Chemotherapy in HEmatology and Oncology; A Prospective, Observational, Non-interventional Study
Essai Clinique (Pfizer)   26 février 2024
Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency.
Pharmacogenomics   01 juin 2020
FAM111B Mutation Is Associated With Pancreatic Cancer Predisposition.
Pancreas   13 septembre 2019
Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study.
The oncologist   06 août 2019
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: update to the study protocol for a randomized controlled trial.
Trials   15 janvier 2019
Programme d’éducation thérapeutique en cancérologie (SMILE)
23e Congrès de Pneumologie de Langue Française   01 janvier 2019
PREDOMOS: Precarious Elderly Patient Supported For Cancer Impact on Quality Of Life of a Domotic And Remote Assistance Approach for Elderly Patients Supported For Locally Advanced or Metastatic Cancer, Socially Isolated: Randomized, Comparative, Prospective Multi-Centre Study
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   26 novembre 2018
Predicting chemotherapy toxicity and death in older adults with colon cancer: Results of MOST (Massilia Oncologic Senior Tests) study.
2018 ASCO Annual Meeting I   01 juin 2018
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial.
Trials   12 avril 2017
Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   27 octobre 2015